- State programs could modify formularies
- DHCS may have to disregard measure’s price ceiling
For reprint and licensing requests for this article, click here.
More From Employee Benefit News
Employers brace for another year of rising health benefit costs
With health benefit costs expected to rise 8.2% in 2027, employers are looking for ways to control spending without simply shifting more costs to workers.
With GLP-1s raising costs, employers are finding new ways to reduce spending
As healthcare expenses approach double-digit increases, employers are looking for savings in waste, care delivery, and plan administration before cutting benefits.
What Trump’s ‘Great Healthcare Plan’ means for drug costs and price transparency
The legislation calls on Congress to lower prescription drug costs, shift subsidies directly to consumers, and enforce strict price transparency.
GLP-1s push health plan costs to 15-year high
Rising use of the weight-loss drug is fueling the fastest health plan cost growth in a decade and a half, forcing employers to rethink coverage strategies and cost management.
Benefits Think Preparing benefits for the next wave: Gene therapy medications
As the scope of gene therapy grows, understanding their impact and cost can help organizations decide how to cover them through their healthcare plans.
